Ameriprise Financial Inc Boston Scientific Corp Transaction History

Ameriprise Financial Inc

$358 Billion
Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 6,075,205 shares of BSX stock, worth $459 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

6,075,205

Previous 7,524,629 19.26%

Holding current value

$459 Million

Previous $435 Million 4.35%

% of portfolio

0.12%

Previous 0.13%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $83.5 Million - $99.5 Million	-1,449,424 Reduced 19.26%	6,075,205 $416 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $105 Million - $125 Million	2,165,709 Added 40.41%	7,524,629 $435 Million
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $129 Million - $140 Million	-2,565,258 Reduced 32.37%	5,358,920 $283 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $86.6 Million - $95.2 Million	-1,741,971 Reduced 18.02%	7,924,178 $429 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $3.72 Million - $4.13 Million	-82,520 Reduced 0.85%	9,666,149 $484 Million

Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $10.8 Million - $12.9 Million	-272,316 Reduced 2.72%	9,748,669 $451 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $38.7 Million - $116 Million	1,054,619 Added 11.76%	10,020,985 $388 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $263 Million - $351 Million	7,454,042 Added 492.89%	8,966,366 $334 Million
Q1 2022 May 16, 2022	SELL	$40.9 - $45.1 $20.7 Million - $22.8 Million	-506,366 Reduced 25.08%	1,512,324 $66.6 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $7.22 Million - $8.51 Million	189,647 Added 10.37%	2,018,690 $85.6 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $10.4 Million - $11.6 Million	-252,776 Reduced 12.14%	1,829,043 $79.4 Million
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $10.4 Million - $12 Million	270,550 Added 14.94%	2,081,819 $89 Million
Q1 2021 May 17, 2021	BUY	$35.27 - $39.67 $302,334 - $340,051	8,572 Added 0.48%	1,811,269 $70 Million
Q4 2020 Feb 12, 2021	SELL	$33.15 - $41.97 $103 Million - $131 Million	-3,114,695 Reduced 63.34%	1,802,697 $64.8 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $13.7 Million - $16.8 Million	397,577 Added 8.8%	4,917,392 $188 Million
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $59.4 Million - $76.9 Million	1,965,964 Added 76.98%	4,519,815 $159 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $4.65 Million - $8.22 Million	179,884 Added 7.58%	2,553,851 $83.3 Million
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $1.04 Million - $1.25 Million	-27,587 Reduced 1.15%	2,373,967 $107 Million
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $10.2 Million - $10.9 Million	251,879 Added 11.72%	2,401,554 $97.6 Million
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $1.01 Million - $1.24 Million	-28,909 Reduced 1.33%	2,149,675 $92.4 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $4.23 Million - $5.24 Million	128,585 Added 6.27%	2,178,584 $83.6 Million
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $8.87 Million - $10.9 Million	279,585 Added 15.79%	2,049,999 $72.4 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $2.92 Million - $3.43 Million	88,801 Added 5.28%	1,770,414 $68.4 Million
Q2 2018 Aug 14, 2018	SELL	$26.84 - $34.32 $9.13 Million - $11.7 Million	-340,214 Reduced 16.83%	1,681,613 $55 Million
Q1 2018 May 15, 2018	BUY	$25.2 - $28.54 $1.6 Million - $1.82 Million	63,689 Added 3.25%	2,021,827 $55.2 Million
Q4 2017 Feb 12, 2018	SELL	$24.79 - $29.8 $3.53 Million - $4.25 Million	-142,557 Reduced 6.79%	1,958,138 $48.5 Million
Q3 2017 Nov 07, 2017	BUY	$26.26 - $29.17 $55.2 Million - $61.3 Million	2,100,695	2,100,695 $61.3 Million

Others Institutions Holding BSX

# of Institutions

1,319

Shares Held

1.17B

Call Options Held

5.92M

Put Options Held

5.75M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $108B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Boston Scientific Corp Transaction History